About the event:

Digital therapeutics (DTx) deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage, or treat a broad spectrum of physical, mental, and behavioral conditions. Digital therapeutics form an independent category of evidence-based products within the broader digital health landscape, and are distinct from pure-play adherence, diagnostic, and tele-health products.

The excitement of breakthrough applications in digital therapeutics is tempered with regulatory uncertainty. A number of companies are forging novel paths forward. Our panel discussion will explore some of these approaches and engage the audience in a conversation about what this means for entrepreneurs, as well as for patients.

Speakers:

Veera Anantha: Founder, CTO and President of The Learning Corp

Simon Kennedy: CEO and Founder of TriAxia Health

Ashley Mateus,PHD: VP Decision Support and Strategic Planning at Akili Interactive

About our sponsor Recon Strategy:

Recon Strategy is a boutique strategy consulting firm founded in 2010 by alumni of the Boston Consulting Group. The firm works with executives at leading healthcare organizations on questions relating to vision, strategy, and innovation. Clients across the U.S. include major health systems, payers, biopharma, medtech, and digital health companies. Besides serving some of the best-known names in healthcare, the firm sets aside a quarter of its resources to work on strategy for startups and small nonprofits.